Stock AARTIDRUGS AARTI DRUGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Market Closed - Bombay S.E.
Other stock markets
 06:20:50 2024-05-07 EDT 		5-day change 1st Jan Change
476 INR -3.01% Intraday chart for Aarti Drugs Limited -6.30% -2.67%
05-06 Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
05-03 Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Aarti Drugs Limited Announces Executive Cessation
CI
Ex-dividend day for interim dividend
FA
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility
MT
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra
CI
Transcript : Aarti Drugs Limited, Q3 2024 Earnings Call, Jan 25, 2024
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24
CI
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Transcript : Aarti Drugs Limited, Q2 2024 Earnings Call, Oct 20, 2023
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.
CI
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.
CI
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit
MT
Transcript : Aarti Drugs Limited, Q1 2024 Earnings Call, Jul 24, 2023
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.
CI
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Aarti Drugs Limited authorizes a Buyback Plan.
CI
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AARTIDRUGS Stock
  4. News Aarti Drugs Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW